These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 16545195)

  • 1. [Evolvement in pathogen factor and pathogenesis of Castleman's disease].
    Zhang Y; Li GD; Liu WP
    Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):812-5. PubMed ID: 16545195
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinicopathologic study of Castleman's disease in Korea.
    Kim JE; Kim CJ; Park IA; Kim WH; Seo JW; Jang JJ; Kim CW; Park SH; Lee HS; Chi JG; Kim YI; Ham EK
    J Korean Med Sci; 2000 Aug; 15(4):393-8. PubMed ID: 10983686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Castleman's disease of the abdomen].
    Collet T; Salaün V; Bouin M; Piquet MA; Auriault ML; Dao T; Verwaerde JC; Troussard X
    Ann Med Interne (Paris); 1998 Sep; 149(5):297-9. PubMed ID: 9791566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Castleman's disease, a fatal cause of lymph node enlargement and fever].
    Verhave G; Lettinga KD; van de Wiel BA; Vasmel WL
    Ned Tijdschr Geneeskd; 2009; 153():A485. PubMed ID: 19857312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentric Castleman's disease: an emerging opportunistic infection.
    McCall J; Phillips JC
    J Assoc Nurses AIDS Care; 2013; 24(1):88-90. PubMed ID: 22564919
    [No Abstract]   [Full Text] [Related]  

  • 6. Castleman's disease. Update on pathogenesis.
    Al-Maghrabi JA
    Saudi Med J; 2011 May; 32(5):451-8. PubMed ID: 21556463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediastinal Castleman's disease complicated by follicular dendritic cell tumour.
    Desai SB; Pradhan SA; Chinoy RF
    Indian J Cancer; 2000 Dec; 37(4):129-32. PubMed ID: 12018563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD20 expression in the HHV-8-infected lymphoid cells in multicentric Castleman disease.
    Naresh KN; Trivedi P; Horncastle D; Bower M
    Histopathology; 2009 Sep; 55(3):358-9. PubMed ID: 19723153
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibodies to human herpesvirus 8 in POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes) syndrome with multicentric Castleman's disease.
    Bélec L; Authier FJ; Mohamed AS; Soubrier M; Gherardi RK
    Clin Infect Dis; 1999 Mar; 28(3):678-9. PubMed ID: 10194095
    [No Abstract]   [Full Text] [Related]  

  • 10. High-level human herpesvirus-8 viremia and multicentric Castleman's disease following initiation of highly active antiretroviral therapy.
    Lumley S; Madge S; Nugent D; Ainsworth J; Dervisevic S; Schmitt C; Schulz TF; Johnson MA; Cwynarski K; Webster DP
    AIDS; 2014 Jul; 28(11):1698-700. PubMed ID: 25197975
    [No Abstract]   [Full Text] [Related]  

  • 11. Human herpesvirus 8 and Epstein-Barr virus coinfection in localized Castleman disease during pregnancy.
    Hernández JL; Gómez-Román J; Ramos-Estébanez C; Nan D; Martín-Oviedo J; Riancho JA; González-Macías J
    Haematologica; 2005 Nov; 90 Suppl():ECR35. PubMed ID: 16266926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine and viral load kinetics in human herpesvirus 8-associated multicentric Castleman's disease complicated by hemophagocytic lymphohistiocytosis.
    Zondag TC; Rokx C; van Lom K; van den Berg AR; Sonneveld P; Dik WA; van Doornum GJ; Lam KH; van Laar JA
    Int J Hematol; 2016 Apr; 103(4):469-72. PubMed ID: 26692197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parsonage-Turner syndrome during the treatment of HIV/HHV8-related multicentric Castleman disease.
    Patier de la Peña JL; González-García A; Prieto Pareja E; Norman FF; Rojas Marcos J; Benito Paniagua D
    Rev Clin Esp (Barc); 2014 Mar; 214(2):e15-7. PubMed ID: 24365755
    [No Abstract]   [Full Text] [Related]  

  • 14. HHV-8 linked to Kaposi's sarcoma, Castleman's disease and primary effusion lymphoma in a HIV-1-infected man.
    Bestawros A; Boulassel MR; Michel RP; Routy JP
    J Clin Virol; 2008 Jun; 42(2):179-81. PubMed ID: 18343194
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyaline vascular Castleman's disease: a case report and brief review of the literature.
    van den Berge M; Pauwels P; Jakimowicz JJ; Creemers GJ
    Neth J Med; 2002 Dec; 60(11):444-7. PubMed ID: 12685494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HHV-8: certainties and mysteries].
    Dupin N
    Rev Prat; 2003 Jun; 53(12):1285-8. PubMed ID: 12920934
    [No Abstract]   [Full Text] [Related]  

  • 17. Castleman's disease.
    Palestro G; Turrini F; Pagano M; Chiusa L
    Adv Clin Path; 1999; 3(1-2):11-22. PubMed ID: 10655569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siltuximab: a new option for the management of Castleman's disease.
    Barquero N
    Drugs Today (Barc); 2015 Jan; 51(1):21-8. PubMed ID: 25685858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.
    Bower M; Newsom-Davis T; Naresh K; Merchant S; Lee B; Gazzard B; Stebbing J; Nelson M
    J Clin Oncol; 2011 Jun; 29(18):2481-6. PubMed ID: 21555697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentric Castleman's disease treated with antivirals and immunosuppressants.
    Senanayake S; Kelly J; Lloyd A; Waliuzzaman Z; Goldstein D; Rawlinson W
    J Med Virol; 2003 Nov; 71(3):399-403. PubMed ID: 12966545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.